Results
1
Undervalued Small Caps
1 companies
Kuros Biosciences
Market Cap: CHF 824.7m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 21.50
7D
1.6%
1Y
-26.4%
